CELGENE CORP /DE/ Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CELGENE CORP /DE/.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CELGENE CORP /DE/. CELGENE CORP /DE/ is 10% Owner in BRISTOL MYERS SQUIBB CO ($BMY) and in CELGENE CORP /DE/ ($CELG) and 10% Owner in CELGENE CORP /DE/ ($CELG) and 10% Owner in CASI Pharmaceuticals, Inc. ($CASI) and 10% Owner in Alliqua BioMedical, Inc. ($ALQA) and in ACCELERON PHARMA INC ($XLRN) and 10% Owner in ACCELERON PHARMA INC ($XLRN) and in SUTRO BIOPHARMA INC ($STRO) and 10% Owner in Abraxis BioScience, Inc. ($ABII) and 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and 10% Owner in CRISPR Therapeutics AG ($CRSP).

Latest Insider Trading Transactions of CELGENE CORP /DE/

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ABII, XLRN, ALQA, AGIO, BMY, CASI, CELG, CRSP, STRO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerOption ExerciseX5.8838,979229,1970
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerSellS102.282,241229,2097,008,5107 M to 7 M (-0.03 %)
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyX5.8838,979229,1977,010,7517 M to 7 M (+0.56 %)
Jul 13 2020CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerOption ExerciseX5.8838,979229,1970
Jul 13 2020CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS102.282,241229,2097,008,5107 M to 7 M (-0.03 %)
Jul 13 2020CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyX5.8838,979229,1977,010,7517 M to 7 M (+0.56 %)
Jul 13 2020BMYBRISTOL MYERS SQUI ...CELGENE CORP /DE/10% OwnerOption ExerciseX5.8838,979229,1970
Jul 13 2020BMYBRISTOL MYERS SQUI ...CELGENE CORP /DE/10% OwnerSellS102.282,241229,2097,008,5107 M to 7 M (-0.03 %)
Jul 13 2020BMYBRISTOL MYERS SQUI ...CELGENE CORP /DE/10% OwnerBuyX5.8838,979229,1977,010,7517 M to 7 M (+0.56 %)
Jul 06 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP92.50108,1089,999,9906,971,7726.9 M to 7 M (+1.58 %)
Jul 06 2020CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP92.50108,1089,999,9906,971,7726.9 M to 7 M (+1.58 %)
Jul 06 2020BMYBRISTOL MYERS SQUI ...CELGENE CORP /DE/10% OwnerBuyP92.50108,1089,999,9906,971,7726.9 M to 7 M (+1.58 %)
Nov 14 2019AGIOAGIOS PHARMACEUTIC ...CELGENE CORP /DE/10% OwnerBuyP31.00403,22512,499,9751,777,8241.4 M to 1.8 M (+29.33 %)
Nov 14 2019CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP31.00403,22512,499,9751,777,8241.4 M to 1.8 M (+29.33 %)
Jan 22 2019XLRNACCELERON PHARMA I ...CELGENE CORP /DE/BuyP43.00706,20630,366,8586,824,6856.1 M to 6.8 M (+11.54 %)
Jan 22 2019CELGCELGENE CORP /DE/CELGENE CORP /DE/BuyP43.00706,20630,366,8586,824,6856.1 M to 6.8 M (+11.54 %)
Oct 02 2018STROSUTRO BIOPHARMA IN ...CELGENE CORP /DE/Option ExerciseC0.0018,726,07500
Oct 02 2018STROSUTRO BIOPHARMA IN ...CELGENE CORP /DE/Option ExerciseC0.0018,097,33100
Oct 02 2018STROSUTRO BIOPHARMA IN ...CELGENE CORP /DE/Option ExerciseC0.002,845,11400
Oct 02 2018STROSUTRO BIOPHARMA IN ...CELGENE CORP /DE/Option ExerciseC0.008,338,89200
Oct 02 2018STROSUTRO BIOPHARMA IN ...CELGENE CORP /DE/BuyC0.001,726,19701,726,1970 to 1.7 M
Oct 02 2018CELGCELGENE CORP /DE/CELGENE CORP /DE/Option ExerciseC0.0018,726,07500
Oct 02 2018CELGCELGENE CORP /DE/CELGENE CORP /DE/Option ExerciseC0.0018,097,33100
Oct 02 2018CELGCELGENE CORP /DE/CELGENE CORP /DE/Option ExerciseC0.002,845,11400
Oct 02 2018CELGCELGENE CORP /DE/CELGENE CORP /DE/Option ExerciseC0.008,338,89200
Oct 02 2018CELGCELGENE CORP /DE/CELGENE CORP /DE/BuyC0.001,726,19701,726,1970 to 1.7 M
Jan 23 2018AGIOAGIOS PHARMACEUTIC ...CELGENE CORP /DE/10% OwnerBuyP67.00851,15457,027,3181,374,599523.4 K to 1.4 M (+162.61 %)
Jan 23 2018CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP67.00851,15457,027,3181,374,599523.4 K to 1.4 M (+162.61 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS19.4730,485593,5433,722,5343.8 M to 3.7 M (-0.81 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS19.1087,9911,680,6283,753,0193.8 M to 3.8 M (-2.29 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS19.0412,666241,1613,841,0103.9 M to 3.8 M (-0.33 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS19.254,26382,0633,853,6763.9 M to 3.9 M (-0.11 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS19.225,08097,6383,857,9393.9 M to 3.9 M (-0.13 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS19.7527,990552,8033,863,0193.9 M to 3.9 M (-0.72 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS20.0026,010520,2003,891,0093.9 M to 3.9 M (-0.66 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS19.76256,0005,058,5603,917,0194.2 M to 3.9 M (-6.13 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS19.2580,0001,540,0004,173,0194.3 M to 4.2 M (-1.88 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS19.02158,7183,018,8164,253,0194.4 M to 4.3 M (-3.60 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS18.4451,282945,6404,411,7374.5 M to 4.4 M (-1.15 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS18.39105,0001,930,9504,463,0194.6 M to 4.5 M (-2.30 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS17.6715,000265,0504,568,0194.6 M to 4.6 M (-0.33 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS17.1914,907256,2514,583,0194.6 M to 4.6 M (-0.32 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS17.7665,0931,156,0524,597,9264.7 M to 4.6 M (-1.40 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS17.2810,000172,8004,663,0194.7 M to 4.7 M (-0.21 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS17.0820,000341,6004,673,0194.7 M to 4.7 M (-0.43 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS18.0616,875304,7634,693,0194.7 M to 4.7 M (-0.36 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS18.5423,000426,4204,709,8944.7 M to 4.7 M (-0.49 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS18.8979,3271,498,4874,732,8944.8 M to 4.7 M (-1.65 %)
Dec 07 2017CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerSellS19.1022,759434,6974,812,2214.8 M to 4.8 M (-0.47 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS19.4730,485593,5433,722,5343.8 M to 3.7 M (-0.81 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS19.1087,9911,680,6283,753,0193.8 M to 3.8 M (-2.29 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS19.0412,666241,1613,841,0103.9 M to 3.8 M (-0.33 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS19.254,26382,0633,853,6763.9 M to 3.9 M (-0.11 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS19.225,08097,6383,857,9393.9 M to 3.9 M (-0.13 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS19.7527,990552,8033,863,0193.9 M to 3.9 M (-0.72 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS20.0026,010520,2003,891,0093.9 M to 3.9 M (-0.66 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS19.76256,0005,058,5603,917,0194.2 M to 3.9 M (-6.13 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS19.2580,0001,540,0004,173,0194.3 M to 4.2 M (-1.88 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS19.02158,7183,018,8164,253,0194.4 M to 4.3 M (-3.60 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS18.4451,282945,6404,411,7374.5 M to 4.4 M (-1.15 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS18.39105,0001,930,9504,463,0194.6 M to 4.5 M (-2.30 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS17.6715,000265,0504,568,0194.6 M to 4.6 M (-0.33 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS17.1914,907256,2514,583,0194.6 M to 4.6 M (-0.32 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS17.7665,0931,156,0524,597,9264.7 M to 4.6 M (-1.40 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS17.2810,000172,8004,663,0194.7 M to 4.7 M (-0.21 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS17.0820,000341,6004,673,0194.7 M to 4.7 M (-0.43 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS18.0616,875304,7634,693,0194.7 M to 4.7 M (-0.36 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS18.5423,000426,4204,709,8944.7 M to 4.7 M (-0.49 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS18.8979,3271,498,4874,732,8944.8 M to 4.7 M (-1.65 %)
Dec 07 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerSellS19.1022,759434,6974,812,2214.8 M to 4.8 M (-0.47 %)
Sep 25 2017XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP37.00745,59227,586,9046,118,4795.4 M to 6.1 M (+13.88 %)
Sep 25 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP37.00745,59227,586,9046,118,4795.4 M to 6.1 M (+13.88 %)
Apr 13 2017ALQAAlliqua BioMedical ...CELGENE CORP /DE/10% OwnerBuyJ0.00296,27707,342,3777 M to 7.3 M (+4.20 %)
Apr 13 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyJ0.00296,27707,342,3777 M to 7.3 M (+4.20 %)
Mar 01 2017ALQAAlliqua BioMedical ...CELGENE CORP /DE/10% OwnerBuyP0.504,000,0002,000,0007,046,1003 M to 7 M (+131.32 %)
Mar 01 2017CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP0.504,000,0002,000,0007,046,1003 M to 7 M (+131.32 %)
Oct 26 2016CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerOption ExerciseC0.004,034,83000
Oct 26 2016CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerBuyP14.00800,15011,202,1004,834,9804 M to 4.8 M (+19.83 %)
Oct 26 2016CRSPCRISPR Therapeutic ...CELGENE CORP /DE/10% OwnerBuyC0.004,034,83004,034,8300 to 4 M
Oct 26 2016CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerOption ExerciseC0.004,034,83000
Oct 26 2016CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP14.00800,15011,202,1004,834,9804 M to 4.8 M (+19.83 %)
Oct 26 2016CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyC0.004,034,83004,034,8300 to 4 M
Jan 11 2016XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP40.00800,00032,000,0005,372,8874.6 M to 5.4 M (+17.49 %)
Jan 11 2016CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP40.00800,00032,000,0005,372,8874.6 M to 5.4 M (+17.49 %)
May 04 2015ALQAAlliqua BioMedical ...CELGENE CORP /DE/10% OwnerBuyP4.55659,3402,999,9973,046,1002.4 M to 3 M (+27.62 %)
May 04 2015CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP4.55659,3402,999,9973,046,1002.4 M to 3 M (+27.62 %)
May 06 2014CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP42.861,100,00047,146,0004,572,8873.5 M to 4.6 M (+31.67 %)
Apr 15 2014CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerOption ExerciseA10.50142,8571,499,999142,857
Apr 15 2014CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP7.00714,2865,000,0022,386,7601.7 M to 2.4 M (+42.71 %)
Apr 15 2014ALQAAlliqua BioMedical ...CELGENE CORP /DE/10% OwnerOption ExerciseA10.50142,8571,499,999142,857
Apr 15 2014ALQAAlliqua BioMedical ...CELGENE CORP /DE/10% OwnerBuyP7.00714,2865,000,0022,386,7601.7 M to 2.4 M (+42.71 %)
May 06 2014XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP42.861,100,00047,146,0004,572,8873.5 M to 4.6 M (+31.67 %)
Jan 29 2014CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP50.00300,00015,000,0003,472,8873.2 M to 3.5 M (+9.46 %)
Jan 29 2014XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP50.00300,00015,000,0003,472,8873.2 M to 3.5 M (+9.46 %)
Sep 26 2013CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerOption ExerciseC0.001,990,44600
Sep 26 2013CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerOption ExerciseJ0.0036,49600
Sep 26 2013CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerOption ExerciseC0.00457,87500
Sep 26 2013CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP15.00666,66710,000,0053,172,8872.5 M to 3.2 M (+26.60 %)
Sep 26 2013CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyC0.001,990,44602,506,220515.8 K to 2.5 M (+385.91 %)
Sep 26 2013CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyJ0.0057,8990515,774457.9 K to 515.8 K (+12.65 %)
Sep 26 2013CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyC0.00457,8750457,8750 to 457.9 K
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerOption ExerciseC0.001,990,44600
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerOption ExerciseJ0.0036,49600
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerOption ExerciseC0.00457,87500
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP15.00666,66710,000,0053,172,8872.5 M to 3.2 M (+26.60 %)
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyC0.001,990,44602,506,220515.8 K to 2.5 M (+385.91 %)
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyJ0.0057,8990515,774457.9 K to 515.8 K (+12.65 %)
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyC0.00457,8750457,8750 to 457.9 K
Oct 18 2010CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyP0.0040,735,3000100-40,735,200 to 100 (-100.00 %)
Oct 18 2010ABIIAbraxis BioScience ...CELGENE CORP /DE/10% OwnerBuyP0.0040,735,3000100-40,735,200 to 100 (-100.00 %)
Apr 01 2005CASICASI Pharmaceutica ...CELGENE CORP /DE/10% OwnerOption ExerciseX1.507,000,00010,500,0000
Apr 01 2005CASICASI Pharmaceutica ...CELGENE CORP /DE/10% OwnerBuyX1.507,000,00010,500,00023,750,00016.8 M to 23.8 M (+41.79 %)
Apr 01 2005CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerOption ExerciseX1.507,000,00010,500,0000
Apr 01 2005CELGCELGENE CORP /DE/CELGENE CORP /DE/10% OwnerBuyX1.507,000,00010,500,00023,750,00016.8 M to 23.8 M (+41.79 %)

Page:   1